AI assistant
INSMED Inc — Director's Dealing 2016
Oct 4, 2016
30150_dirs_2016-10-04_37d0d2f0-1fad-4ed5-88a8-b9f16781cf27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2016-10-03
Reporting Person: Adsett Roger (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-10-03 | Stock Option | $14.56 | A | 88060 | Acquired | 2026-10-03 | Common Stock (88060) | Direct |
Footnotes
F1: In connection with the appointment of Mr. Adsett, the Company made an inducement grant of stock options to Mr. Adsett to purchase a total of 88,060 shares of the Company's common stock. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) on the first anniversary of the date of grant and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary of the date of grant and each six month anniversary date thereafter through the fourth anniversary of the date of grant.